Trial site
Peak Gastroenterology Associates
- 28running trials
- 10closed trials
The trials here
What the 38 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis18 trials
- Crohn's disease9 trials
- Primary biliary cholangitis4 trials
- Coeliac disease2 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Liver cirrhosis2 trials
- Asthma1 trial
- Eosinophilic oesophagitis1 trial
- High blood pressure1 trial
- Phase
- Phase 317 trials
- Phase 215 trials
- Phase 2/33 trials
- Early phase 11 trial
- Phase 1/21 trial
- Phase 41 trial
- Status
- Recruiting17 trials
- Active, not recruiting11 trials
- Completed9 trials
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC9 trials
- Ipsen4 trials
- Boehringer Ingelheim3 trials
- Eli Lilly and Company3 trials
- Hoffmann-La Roche3 trials
- and 11 more
Running trials
Recruiting
Study of Seladelpar and Cilofexor in Participants With Primary Biliary Cholangitis
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Recruiting
Recruiting
Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Active, not recruiting
Recruiting
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease7 recruiting
- Ulcerative colitis6 recruiting
- Primary biliary cholangitis2 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Liver cirrhosis1 recruiting
Closed trials
Completed
Completed
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Completed
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Completed
24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)
Completed
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
Completed
Completed
Completed
Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis
Terminated
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026